CB1 Capital Management predicts Cannabis could disrupt the healthcare industry in a big way. The firm's Founding Partner and Chief Investment Officer Todd Harrison explains why he thinks medical marijuana will migrate from state dispensaries, to become medicine prescribed by doctors through insurance in the next decade.
Harrison says the only way the U.S. government would get their hands on the money in this market opportunity is through the FDA. "That's where we think it goes, follow the money," says Harrison.
"This is not so much a trade about commerce, as it is a trade about healthcare," said Harrison. "We think that this is going to migrate towards medicine." One of CB1 Capital Management's holdings GW Pharmaceuticals is up 30 percent over the past three months. Harrison expects this company to publish research showing the efficacy of cannabis treatment this summer.
TIME reveals its 2026 Best Inventions list of 300 breakthroughs, featuring Apple CEO John Ternus and the iPhone Duo as he shares his vision for the future.
Seth Goldstein, Senior Equity Analyst at Morningstar, examines Tesla’s new Roadster, SpaceX merger speculation and the race to make robotaxis profitable.
Antoine Marcel, founder and CEO of Flourish Robots, discusses how its AI-powered robot could transform household chores and bring home robotics to the masses.
Chris Stafford, haunted house expert and CEO of Thirteenth Floor Entertainment, reveals the business behind Halloween’s biggest scares and immersive attractions
